In a preceding communication we have demonstrated that the relative immunogenicity of the murine H-7.1 alloantigen, as inferred from survival times of H-7.1-incompatible skin grafts, is determined by genes in the D region of the major histocompatibility (H-2)complex (1). Similar observations have been made previously for the male-specific (H-Y) antigen by other investigators (2, 3). The effects of these H-2.1inked genes on the ability of non-H-2-incompatible cells to stimulate mixed lymphocyte culture (MLC) I reactions or function as targets for cytotoxic effectors have not been investigated.
Extensive evidence has confirmed that the alloantigens which most strongly stimulate T-lymphocyte proliferation in primary MLC are coded for by genes in the H-2 complex (4) and more specifically by genes in the I region (5, 6 ). H-2K and H-2D alloantigens, most notably those generated by recent mutations, are stimulatory in MLC, although to a lesser degree than I region MLC determinants (6) (7) (8) (9) . However, the only individual non-H-2 alloantigens shown to be strongly stimulatory in primary MLC are antigens coded for by alleles at the Mls locus (10, 11) . Marginally significant stimulation has been observed with single non-H-2 histocompatibility antigens (12) and Thy-1 antigen (13) in primary MLC. Additional attempts, including ours reported in this paper, have not resulted in significant stimulation by single non-H-2 antigens in primary MLC.
In this communication we report that nylon wool purified, splenic T lymphocytes obtained from donors primed with H-4-or H-7-incompatible spleen cells or skin grafts, proliferate in response to incompatible lymphocytes in secondary MLC. Further, we present results obtained in experiments intended to elucidate the role of H-2-1inked genes in determining the relative ability of H-7.1-incompatible lymphocytes to stimulate proliferation in secondary MLC and * Supported by American Cancer Society grant IM-90 and National Institutes of Health grant (CA-14089).
Leukemia Society of America Fellow. i Abbreviations used in this paper: H, histocompatibility; MLC, mixed lymphocyte culture; SRBC, sheep erythrocytes. In a companion paper we presented evidence indicating that a gene(s) in the H-2D region regulates the relative rejectability of H-7.1-incompatible skin grafts (1). We have further investigated the possible role of this gene in regulating the ability of H-7.1-incompatible spleen cells to stimulate proliferation in MLC.
Preimmunized (BIO.C(H-2b)-H-7 b x BIO-H-2aH-7b
)F1 responder cells were mixed with H-7.1-incompatible, H-2-compatible stimulator cells from donors with different H-2 haplotypes. The results of these assays are presented in Table HI . B10 stimulators cells were optimally stimulatory (h = 28,505 at 5 days) whereas B10.A stimulators were comparatively ineffective (h = 2,186 at 5 days). To insure that proliferation of F1 responder cells was H-7.1-specific and not specific for Hh-1 determinants (23, 24) expressed on homozygous H-2 b stimulators, two controls were performed. First, B10.C(H-2 b)-H-7 ~ and B10-H2all-7 b parental strain spleen cells were tested for stimulation and were found to be equally nonstimulatory. These cells are H-7 compatible but should express Hh-1 determinants identical to those of B10 and B10.A stimulators, (Table III) . However, B10.A(5R) spleen cells were similar in stimulatory capacity to B10.A spleen cells. The haplotype origins of the H-2 regions of these H-2 recombinants (Table III) suggests that the gene controlling the efficacy of H-7.1-incompatible stimulatorsmaps in the region telomeric to the H-2 ~ recombination site. The high proliferation induced by B6-Tla a spleen cells further maps the gene to the D region as defined by the H-2 ~ recombination site on the centromeric side and the site of the recombination separating H-2 ~ and Tla a in the production of B6-Tla a on the telomeric side. It should be noted that B6-Tla a differs from B10 at a minimum of one non-H-2 H locus independent of H-2 (25) and at H-31 and H-32 linked to H-2 (26) . The Tla ~ allele derived from the H-2 a haplotype is shared by BIO-H-2aH-7 b and B6-T/a% therefore complementing for the H-31 and H-32 alleles of B6-Tla ~ which map in the H-2D-Tla interval (27) . The inability to detect proliferation in primary MLC to single non-H-2 H antigens makes a primary response to non-H-2 H antigens of B6-Tla a not shared with B10 highly unlikely. The single exception to the D region map position of the operative regulatory gene is the stimulatory capacity of B10.A(18R) spleen cells. B10.A(18R) spleen cells were intermediate stimulators (A = 11,853 cpm at 5 days) despite the fact that they are H-2Da; this observation suggests that the control of stimulating capacity of H-7.1-incompatible stimula- (H-7 and H-4) stimulate significant proliferation of responder T lymphocytes in secondary mixed lymphocyte culture. In addition, the stimulatory capacity of H-7.1-incompatible stimulators and susceptibility of targets to lysis are regulated by a gene(s) in the H-2D region. It would appear that in vivo priming is required to expand the number of T cells-specific for single non-H-2 H antigens enabling detection of proliferation in MLC. This supposition would predict that the frequency ofT lymphocytes responsive to alloantigens in MLC range in frequency from those T cells in relatively high frequency, responsive to I region determinants and Mls antigens, to those T cells responsive to single non-H-2 histocompatibility alloantigens normally present in relatively low frequency. The relative levels of proliferation in MLC across H-2 and HLA barriers were believed to correlate inversely with the probability of graft rejection across the same barriers, until a lack of correlation was shown, initially for HLA (28) and subsequently for H-2 (5). On the contrary, the results in this communication and preliminary data on Ir gene control of the response to single non-H-2 H antigens demonstrate that relative levels of proliferation in secondary MLC inversely correlate with relative survival times of skin allografts transplanted across the same non-H-2 H barriers. The survival time of H-4.2-incompatible skin grafts is dependent on recipient H-2 genotype (29) The actual stimulator cell in mitomycin C-treated, H-7.1-incompatible spleen cell suspensions has not been identified. It has been inferred that non-H-2 H antigens are expressed on macrophages, based on the observations that: (a) non-H-2-incompatible hyperimmune spleen and peritoneal exudate cells (which transfer anti-SRBC immunity) are inactivated by recipients in vivo (30) (31) (32) (33) and (b) the cells actually required for transfer of immunity are macrophages (34) . We are presently investigating the identity of the actual cell stimulating non-H-2 H antigen-specific proliferation in secondary MLC. The stimulation of non-H-2 H antigen-specific proliferation may be analogous to stimulation of guinea pig T cells by antigen-pulsed macrophages (30) . If this situation were the case, an extensive study of this in vitro response may yield important information regarding the genetic control of macrophage:T cell and target:effector interactions.
The antigenic specificity of H-2D control of relative immunogenicity of non-H-2 H antigens is presently unknown. We are examining the effects of H-2D region genes on the immunogenicity of H-4, H-3, and H-Y alloantigens. It has been suggested that H-Y immunogenicity is controlled by a gene(s) in the H-2K end (c) although the data do not strongly support the proposed mapping. However, H-2D control of susceptibility of H-Y-positive lymphoblast targets to H-Y-specific lysis would account for the difference in susceptibility of B10.A and B10.A(2R) male targets (35) haplotype, suggesting classical restriction is operative in vitro but in a manner considerably more complex than predicted by any current restriction theory, either altered self or dual recognition. The unexpected observation that H-7.1-specific effector cells generated by boosting with B10.A stimulators lysed B6-Tla" targets suggests that the previously observed requirement for sharing K or D regions between killer and target is not absolute and can also be satisfied by products of a locus telomeric to H-2D in the Tla region. Further experiments are required to confirm this observation and to map the locus responsible for restriction of H-7.1°specific effectors relative to the other genes in the D-Tla interval. The discrepancy between in vivo and in vitro results indicates that rechallenge with non-H-2-incompatible stimulators in vitro results in either a differentiation of previously unrestricted cytotoxic T cells into T cells with restricted cytotoxic activity or selective amplification of a subset of cytotoxic T cells preferentially reactive with targets expressing a particular H-2 haplotype. Selective depletion of proliferating T cells in MLC through the use of high levels of [3H]thymidine or treatment with bromodeoxyuridine and light and restimulation of the remaining cells should allow us to discriminate between these two alternatives.
Summary
The relative immunogenicity of the H-7.1 alloantigen has been shown in a previous communication to be regulated by a gene in the D region of the mouse major histocompatibility (H-2) complex. The level of relative immunogenicity was inferred from survival times of H-7.1-incompatible skin grafts donated by donors with different H-2 haplotype origins of H-2D region genes. In this communication we report the results of an extension of these previous investigations into the possible role of H-2D region genes in controlling the capacity of H-7.1-incompatible lymphocytes to stimulate H-7.1-speciflc mixed lymphocyte culture proliferation and generation of cytotoxic effector cells. The results reported herein demonstrate that the H-2D genotype of H-7.1-incompatible stimulator cells determines the relative H-7.1-specific capacity of those lymphocytes to stimulate H-7.1-specific proliferation of in vivo primed responder T cells in secondary mixed lymphocyte culture. H-2Db-bearing, H-7. l-incompatible stimulators were significantly more effective in stimulating H-7.1-specific proliferation than H-2Dd-bearing stimulators. As expected, H-2D b, H-7.1-incompatible stimulators were also more effective than H-2D a stimulators in generating H-7.1-specific cytotoxic effector cells. Further, the susceptibility of ~Cr-labeled, H-7.1-incompatible lymphoblast targets to H-7.1-specific lysis was similarly regulated by an H-2D gene. Reciprocal H-2 restriction (F~ cells are capable of killing only the cells bearing the immunizing cell parental H-2 haplotype) observed by other investigators for cytolysis of non-H-2-incompatible targets was not observed. H-2D a-bearing, H-7.1-incompatible stimulators stimulated generation of cytotoxic effectors capable of detectably lysing H-2D b but not H-2Da-bearing, H-7.1-incompatible targets. The impact of these observations on the proposed models for H-2 restriction of non-H-2 histocornpatibility antigen-specific cytolysis is discussed.
